(56 days)
SomnoTraxx System (K030797)
No
The description focuses on data transmission, storage, and display, with no mention of AI or ML algorithms for analysis or interpretation.
No.
The device is described as a system for wireless transmission and display of usage and therapeutic information, intended to "augment the standard follow-up care" for obstructive sleep apnea. It does not provide therapy itself, but rather facilitates the monitoring and management of therapeutic information from CPAP systems.
No
The device is intended to augment standard follow-up care for adult patients with obstructive sleep apnea by providing wireless transmission and display of usage and therapeutic information from CPAP systems. It does not perform diagnosis itself, but rather collects and displays data for clinicians to review.
No
The device description explicitly states that the system comprises two distinct components: ResTraxx or S8 ResTraxx (optional wireless modules that attach to flow generators) and the Server System (software modules). The ResTraxx/S8 ResTraxx components are hardware modules that electrically connect to the flow generators.
Based on the provided information, the ResTraxx Data Center system is not an IVD (In Vitro Diagnostic) device.
Here's why:
- Intended Use: The intended use is to "augment the standard follow-up care of adult patients diagnosed with obstructive sleep apnea by providing wireless transmission and display of usage and therapeutic information." This involves monitoring and managing a patient's condition based on data from a medical device (CPAP system), not analyzing biological samples (like blood, urine, or tissue) to diagnose or monitor a disease.
- Device Description: The device collects and transmits data from a CPAP machine. It does not interact with or analyze any biological specimens from the patient.
- Lack of IVD Characteristics: The description does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological samples.
- Providing diagnostic information based on biological sample analysis.
- Using reagents or assays.
The ResTraxx Data Center system is a data management and transmission system for a medical device used in the treatment of sleep apnea. It falls under the category of a medical device, but not specifically an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The ResTraxx Data Center system is intended to augment the standard follow-up care of adult patients diagnosed with obstructive sleep apnea by providing wireless transmission and display of usage and therapeutic information.
It is intended to be used in the home only and with compatible S7 Elite, AutoSet Spirit, AutoSet Respond & S8 Series CPAP Systems, positive airway pressure flow generators.
Product codes
73 BZD
Device Description
The performance and functional characteristics of the ResTraxx Data Center System includes all the performance characteristics of the predicate device, SomnoTraxx System (K030797).
The ResTraxx Data Center System is designed to function with ResMed's S7™ Elite, AutoSet™ Respond and AutoSet Spirit™ CPAP Systems and S8 Series CPAP Systems for the transfer, storage, retrieval and display of stored information from the flow generators to the clinician, via wireless transmission and display of stored information from the flow generators to the clinician. There is no patient access to the system.
The ResTraxx Data Center System comprises two distinct components, ResTraxx or S8 ResTraxx and a Server System. Data taken from the flow generator is transmitted via a wireless network, stored in the Server System. Data then is retrieved and displayed on the Clinical reviewer's PC.
ResTraxx™ and S8 ResTraxx™ are optional wireless modules designed to attach to ResMed S7™ Elite, AutoSet Respond and AutoSet® Spirit or S8 Series flow generators respectively using a specially connected cable and an existing docking mechanism. This mechanism allows the device to be physically connected with the existing expansion port located at the rear of the flow generator. When attached, the Res Traxx can automatically collect patient and machine information stored within the flow generator's memory.
The ResTraxx and S8 ResTraxx sends information utilizing existing messaging networks providing wireless coverage to large portions of the US population.
Server System – The Server System consists of several functional software modules that are designed to retrieve information from ResMed flow generators through the ResTraxx and S8 ResTraxx, encrypt the information, send the information into the wireless messaging network, store the information in a database and provide a secure interface to other applications which use the information.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
adult patients
Intended User / Care Setting
used in the home only / clinician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Design and Verification activities were performed on the ResTraxx Data Center System as a result of the Design and product requirements. All tests confirmed the product met the acceptance criteria.
risk and product requirements. All tests confirmed the product to the prodicat risk and product requirements. 7 in tots sommitally Equivalent to the predicate device.
ResMed has determined that the new device is Substantially Equivalent used in the Reswed has delemined that the new oction to safety and effectiveness when used in the Res irax Data Center System nas not allery and outly antients. The new device complies with the
management of Obstructive Sleep Apnea (OSA) in adult patients. management of Obstructive Gloop Aprila (Coop) in the FDA guidance documents:
- FDA Draft Reviewer Guidance for Ventilators (July 1995) A
- FDA reviewer's and industry, Guidance for the content of premarket submissions for software A contained in medical devices, May 1998.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
SomnoTraxx System (K030797)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 868.5905 Noncontinuous ventilator (IPPB).
(a)
Identification. A noncontinuous ventilator (intermittent positive pressure breathing-IPPB) is a device intended to deliver intermittently an aerosol to a patient's lungs or to assist a patient's breathing.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the word "RESMED" in bold, black letters. The letters are capitalized and evenly spaced. The font appears to be sans-serif.
R
Section 4(6) Rule 506(b) Private Placement Notification
ResTraxx Data Center Traditional 510(k) Premarket Notification
| 510(k) Summary - ResTraxx Data Center | |
|---|---|
| JUL 1 5 2005 | |
| Date Prepared | 5th April, 2005 |
| Official Contact | Dr Lionel King |
| V.P., Quality Assurance & Regulatory Affairs | |
| ResMed Ltd | |
| 97 Waterloo Road | |
| North Ryde, NSW 2113 | |
| Australia | |
| Tel: +61 (2) 9886 5000 | |
| Fax: +61 (2) 9878 5517 | |
| Classification Reference | 21 CFR 868.5905 |
| Product Code | 73 BZD |
| Common/Usual Name | CPAP System / Non continuous Ventilator (with accessory) |
| Proprietary Name | ResTraxx Data Center System |
| Predicate Device(s) | SomnoTraxx System (K030797) |
| Reason for submission | New Device |
| Indications for Use | The ResTraxx Data Center system is intended to augment the standard |
| follow-up care of adult patients diagnosed with obstructive sleep apnea by | |
| providing wireless transmission and display of usage and therapeutic | |
| information. |
It is intended to be used in the home only and with compatible S7 Elite,
AutoSet Spirit, AutoSet Respond & S8 Series CPAP Systems, positive
airway pressure flow generators. |
1
RESMED
Substantial Equivalence
The new device has the following similarities to the previously cleared predicate device.
- Similar intended use A
- Same operating principle A
- Same technologies A
- Same manufacturing process A
Design and Verification activities were performed on the ResTraxx Data Center System as a result of the Design and product requirements. All tests confirmed the product met the acceptance criteria.
risk and product requirements. All tests confirmed the product to the prodicat risk and product requirements. 7 in tots sommitally Equivalent to the predicate device.
ResMed has determined that the new device is Substantially Equivalent used in the Reswed has delemined that the new oction to safety and effectiveness when used in the Res irax Data Center System nas not allery and outly antients. The new device complies with the
management of Obstructive Sleep Apnea (OSA) in adult patients. management of Obstructive Gloop Aprila (Coop) in the FDA guidance documents:
- FDA Draft Reviewer Guidance for Ventilators (July 1995) A
- FDA reviewer's and industry, Guidance for the content of premarket submissions for software A contained in medical devices, May 1998.
Intended Use
The ResTraxx Data Center system is intended to augment the standard follow-up care of adult patients The Res Fraxx Data Center System is intended to dagment the Standard of usage and therapeutic information.
lt is intended to be used in the home only and with compatible ResMed S7 Elite, AutoSet Spirit, AutoSet It is intended to be used in the nomo sing ative airway pressure flow generators.
Device Description
The performance and functional characteristics of the ResTraxx Data Center System includes all the The performance an the predicate device, SomnoTraxx System (K030797).
The ResTraxx Data Center System is designed to function with ResMed's S7™ Elite, AutoSet" Respond The Res Halx Dala Cellier Systems and S8 Series CPAP Systems for the transfer, storage, retireval and AutoSet Spint™ CPAF Systems and Oo Generators to the clinician, via wireless transmission and
and display of stored information from the flow generators to the care no and display of stored mornation from the liew generations of the system. There is no patient access to the system.
The ResTraxx Data Center System comprises two distinct components, ResTraxx or S8 ResTraxx and The ResTrax Data Center System comprises two also is transmitted via a wireless network, stored in the Server System. Data taken from the now gonorator is thanks and displayed on the Clinical reviewer's PC.
ResTraxx™ and S8 ResTraxx™ are optional wireless modules designed to attach to ResMed S7™ ResTraxx™ and 30 Nes Haxx__ are optional wirersos mow generators respectively using a Ellie, AutoSet Respond and AutoSel® Opine or So Senally connected watte existing
docking mechanism. This mechanism allows the device to be existing and SS Post docking filectialism. This nechanism anows and concerner works. When attached, the Res Traxx
expansion port located at the rear of the flow generator. When attached, the Re expansion port located at the rear of the now generator - within the flow generator's memory.
can automatically collect patient and machine information stored within the flow
2
Image /page/2/Picture/2 description: The image shows the word "RESMED" in bold, black font. The letters are capitalized and evenly spaced. The font appears to be sans-serif.
The ResTraxx and S8 ResTraxx sends information utilizing existing messaging networks providing wireless coverage to large portions of the US population.
Server System – The Server System consists of several functional software modules that are designed a Server System – The Server Official or of SesTraxx or SesTraxx or S8 ResTraxx and a
to retrieve information from ResMed flow generators through the ResTraxx and a to retrieve information from the information in a database and provide a secure into the wireless messaging network, store the mornation in a datababe and provide of the enternation.
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/11 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES . USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, stacked on top of each other.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 1 5 2005
ResMed Limited c/o Mr. David D'Cruz 14040 Danielson St. Poway, California 92064-6857
Re: K051314
Trade/Device Name: Res Traxx Data Center Regulation Number: 21 CFR 868.5905 Regulation Name: Noncontinuous Ventilator (IPPB) Regulatory Class: II Product Code: BZD Dated: April 5, 2005 Received: May 20, 2005
Dear Mr. D'Cruz:
We have reviewed your Section 510(k) premarket notification of intent to market the device We have reviewed your Section 910(x) premaine is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for use stated in the encrosule) to regally manation in the Medical Device American on to commerce prior to May 20, 1970, the enaounce with the provisions of the Federal Food. Drug, devices that have been recials.ned in acceraanse was a premarket approval application (PMA).
and Cosmetic Act (Act) that do not require approval of a premarket approval appli and Cosmelle Act (Act) that to not require approvine capprovisions of the Act. The Y ou may, therefore, market the devices, books of the coursements for annual registration, listing of general controls provisions of the Fist labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it If your device is Classifica (SCC above) into existing major regulations affecting your device can
may be subject to such additional controls. Existing major research and li may be subject to such additional controller "Little 21, Parts 800 to 898. In addition, FDA may be found in the Ood of Pouch Snowning your device in the Federal Register.
4
Page 2 - Mr. D'Cruz
Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that FDA s issualice of a subscribe with other requirements of the Act
that FDA has made a determination that your device of a cranice. You must that FDA has made a delerimiation that your are reas by other Federal agencies. You must or any Federal statures and regulations administed to: registration and listing (21
comply with all the Act's requirements, including, but not regultements as set comply with all the Act S requirements; mercements and in the practice requirements as set CFR Part 807); labeling (21 CFX 1 at 601); good manaxt 820); and if applicable, the electronic
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicab forth in the quality systems (Q5) regalatesin (Sections 531-542 of the Act); 21 CFF 1000-1050.
product radiation control provisions (Sections 531-542 of the Acchae Section S product radiation control provisions (occtions our device as described in your Section 510(k)
This letter will allow you to begin marketing your device of your device to a le This letter will anow you to begin manxemily of substantial equivalence of your device to a legally premarket notification. The PDA midning of succements of the more and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please If you desire specific advice for your de need on Also, please note the regulation entitled, and the move obtain contact the Office of Compliance at (210) 216 of Part 807.97). You may obtain
"Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain "Misbranding by reference to premarket itstitutions of the Act from the Division of Small
other general information on your responsibilities under the Act from pumber (800) 6 other general information on your responsible and at its toll-free number (800) 638-2041 or Manufacturers, International and Consulter Assistance of to corport/industry/support/index.html.
Sincerely yours,
Suytte of. Michael Onis
Chiú Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
... ..
Enclosure
5
ResTraxx Data Center Traditional 510(k) Premarket Notification
RESMED
Indication for Use
510(k) Number (if known):
・ 、 ResTraxx Data Center
Scale
1:24,000
Device Name:
Indication for Use
The ResTraxx Data Center system is intended to augment the standard follow-up care of adult patients I he Hes Faxx Data Center system is inchient to dagment of the starter.
diagnosed with obstructive sleep apnea by providing wireless transmission and display of usage and therapeutic information.
It is intended to be used in the home only and with compatible S7 Elite, AutoSet Spirit, AutoSet Respond It is intended to be used in the norms shy any any pressure flow generators.
Prescription Use _____________________________________________________________________________________________________________________________________________________________
AND/OR
Over-The-Counter Use__________________________________________________________________________________________________________________________________________________________
(Part 21 CFR 801 Subpart D)
(Part 21 CFR 807 Subpart C)
(Please DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH; Office of Device Evaluation (ODE)
Qum Sylon
(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, De
510(k) Number:
Page 1 of_ 1_